搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
搜狐
11 天
关于勒那卡韦Sunlenca(lenacapavir)的注意事项
禁止与强CYP3A诱导剂合用Sunlenca。 【警告和注意事项】 1.免疫重建综合征据报道,在接受联合抗逆转录病毒(ARV)治疗的患者中,出现了发病时间不定的自身免疫性疾病。 2.Sunlenca的长效特性和潜在相关风险:Sunlenca的残留浓度可能会在患者的体循环中保留长达12个月 ...
搜狐
11 天
奥鲁他尼布 olutasidenib 适用于白血病(AML)
olutasidenib是一种突变异柠檬酸脱氢酶-1 (IDH1)的小分子抑制剂。在AML患者中,易感性IDH1突变被定义为导致白血病细胞中2羟基戊 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Helene now hurricane
Workers lose arbitration
Sounds nuclear alarm
Penn suspends law professor
Calls strike against 'LoL’
Campaign office damaged
KY sheriff pleads not guilty
US to waive visas for Qatar
Chemical leak in OH county
Confirms lineup
Briefed on Iranian threats
Dog food recalled
Texas AG appeal denied
First transparency report
To cut Atlanta service, jobs
Shippers seek workarounds
WA abortion pill stockpile
Senate report details lapses
States with election changes
Online spending may rise
China conducts ICBM test
Fat Bear Week coming up
Explosion at CA courthouse
New COVID, flu shots
Exec apologizes for outage
CA new gun control laws
School book bans surge
Israel intercepts first missile
反馈